Corporate
News
LR Health & Beauty SE publishes figures for the first half of 2026
- H1 2026 sales reached EUR 118.6 million, with normalized EBITDA of EUR 8.7 million
- In the transformation year 2026, LR systematically advances strategic initiatives to position the organization for the future
- Business Days in September boost international partner community activities
Ahlen, 24 August 2026 – LR Health & Beauty SE, Europe’s leading social commerce company for high-quality nutritional supplements and beauty products, has today published its figures for the second quarter and first half of 2026.
In the second quarter of the 2026 financial year, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 57.8 million (Q2 2025: EUR 68.9 million), representing a decrease of 16.1% compared with the same period last year. For the first half of the year, sales amounted to EUR 118.6 million, which was 17.0% lower than the previous year’s level of EUR 142.9 million. Sales performance continued to be characterized by a challenging market environment, with consumer sentiment generally subdued.
In addition to the decrease in sales, one-off effects relating to the reorganization of the financing structure had a particularly negative impact on earnings. In the first six months of 2026, LR Health & Beauty SE generated reported EBITDA of EUR 3.9 million, which represents a decrease compared with the previous year (H1 2025: EUR 13.3 million). Normalized EBITDA amounted to EUR 8.7 million in the first six months of 2026, compared with EUR 15.3 million in the same period of the previous year.
Jörg Körfer, CEO of LR Health & Beauty SE, comments: “With the successful completion of our financial realignment, we have already made significant progress in the transformation year 2026 towards positioning LR for the future. On this basis, we are consistently driving forward our strategic initiatives, with a particular focus on developing the organization sustainably and enabling future growth at LR. At the same time, we are looking forward to the upcoming Business Days in September. They provide the ideal platform to further deepen our dialogue with our partner community, jointly advance our activities and provide important impetus for LR’s future.”
As part of its strategic initiatives, LR is implementing targeted measures in key areas that are crucial to the company’s future. These include investments in production at the Ahlen site, the optimization of logistics processes and support for international growth. An important element of these initiatives is the expansion of in-house production, which will enable LR to further strengthen its own value creation and provide additional flexibility to scale the business. To this end, LR is also driving forward the digitalization and automation of internal processes.
The full report for the second quarter and the first six months of 2026 is available online from today on the company’s website at https://ir.lrworld.com/.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
Contact:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
IR Contact:
cometis AG
Thorben Burbach
Friedrichstraße 22
65185 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
LR Topco S.à r.l. publishes half-year report as of 30 June 2026
Luxembourg, 24 August 2026 – LR Topco S.à r.l., the parent company of LR Health & Beauty SE and its subsidiaries, which was founded in February 2026, has published its half-year report as of 30 June 2026. The company is the issuer of the new subordinated 2026/2031 bond (“Junior Bonds”, ISIN NO0013756064) with a volume of EUR 27.5 million. Further information on the business performance of the LR Group is published by LR Health & Beauty SE.
The full reports from LR Topco S.à r.l. and LR Health & Beauty SE for the second quarter and the first half of 2026 respectively are available online from today on the company’s website at https://ir.lrworld.com/.
IR Contact:
cometis AG
Thorben Burbach
Friedrichstraße 22
65185 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
LR Health & Beauty SE publishes final 2025 annual report and continues to execute its strategic initiatives
- Preliminary FY 2025 sales and EBITDA confirmed
- Solid financial footing provides scope to consistently advance strategic initiatives aimed at optimizing production, logistics and sales
Ahlen, 4 August 2026 – LR Health & Beauty SE, Europe’s leading social commerce company for high-quality nutritional supplements and beauty products, has today published its final annual report for 2025.
The sales and earnings figures for the 2025 financial year, as communicated in the preliminary results, are thereby confirmed: for the full 2025 year, the LR Group generated sales (revenue from goods sold) of EUR 277.1 million (2024: EUR 289.2 million). Meanwhile, one-off effects arising from the reorganization of the financing structure weighed on earnings performance. For the full 2025 year, this resulted in reported EBITDA of EUR 16.5 million, compared with EUR 27.3 million in the previous year. Normalized EBITDA for the year amounted to EUR 22.5 million (2024: EUR 32.6 million).
Jörg Körfer, CEO of LR Health & Beauty SE, comments: “The 2026 financial year is a transitional year for LR, during which we have laid the groundwork – both financially and strategically – for sustainable business growth and performance. The newly established financing structure gives us the momentum we need to continue to consistently pursue the initiatives we have launched in production, logistics and sales in the second half of the year. In this context, we are committed to working closely with our partners and are continuing to expand these relationships internationally.”
Expanding in-house production is a key strategic pillar. As part of its strategic measures, LR is investing over 2 million euros in a new, high-performance production line, thereby centralizing the manufacture of the 5in1 product category entirely at its site in Ahlen in the future. This includes the established products LR 5in1 Beauty Elixir and LR 5in1 Men’s Shot. The new production facility is designed to have an annual capacity of up to 40 million units and also paves the way for further product innovations in the area of modern nutritional supplement concepts.
The full 2025 Annual Report is available from today on the company’s website at https://ir.lrworld.com.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
Contact:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
IR Contact:
cometis AG
Thorben Burbach
Friedrichstraße 22
65185 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
LR Health & Beauty SE Successfully Completes Financial Realignment – Strong Foundation for Growth and Long-Term Partnerships
- Successful completion of the financial realignment enables full focus on growth and further strengthening operational excellence
- Planned investments in production and logistics will enhance efficiency, flexibility, and delivery capabilities
- Further international growth, including expansion into new markets, targeted
Ahlen, 25 June 2026 – LR Health & Beauty SE, Europe’s leading social commerce company for high-quality nutritional supplements and beauty products, has successfully completed its financial realignment, establishing the foundation for the company’s stable and forward-looking development.
With the achievement of the final milestone, an intensive and demanding process has been successfully concluded. LR has fundamentally realigned its financing structure and significantly strengthened its capital base. An initial financing tranche of EUR 10 million was provided at the end of March, followed by a second tranche of the same amount in June.
Jörg Körfer, CEO of LR Health & Beauty SE, comments: “The past months have been challenging for many parties involved. We are therefore particularly pleased to have successfully completed the company’s financial realignment. We would like to express our sincere gratitude to our sales partners, suppliers, employees, and investors who have accompanied and supported us throughout this period. With our newly established financing structure, we now have a substantially stronger foundation for the future. Our focus is now fully directed towards further strengthening our operational capabilities, driving growth, and sustainably enhancing collaboration with our partners.”
The new financing structure has enabled the company to significantly and sustainably reduce its debt level. Lower debt service requirements create additional flexibility for targeted investments in key future areas of the company. The most important planned initiatives include:
- Investments in production at the Ahlen site to strengthen capacity, efficiency, and flexibility, including the insourcing of a key product
- Further development and optimization of logistics processes to enhance efficiency, delivery performance, and service quality
- Targeted investments to support international growth, including expansion into new markets
Through these measures, LR is strengthening its position as a reliable partner throughout the entire value chain. The company also reaffirms its clear commitment to quality, delivery reliability, and sustainable growth. With the successful completion of the financial realignment, LR is opening a new chapter – built on a solid financial foundation, clear growth ambitions, and a consistent focus on the needs of its partners and customers.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
Contact:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
IR Contact:
cometis AG
Thorben Burbach
Friedrichstraße 22
65185 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
LR HEALTH & BEAUTY SE ANNOUNCES SUCCESSFUL CONCLUSION OF THE WRITTEN PROCEDURE INITIATED ON 19 MAY 2026, FULLY SUBSCRIBED ISSUANCES OF SHARES AND BONDS, ADMISSION TO TRADING OF THE NEW BONDS AND REDEMPTION OF OUTSTANDING SUPER SENIOR BRIDGE BONDS
Ahlen, 5 June 2026 – On 19 May 2026, LR Health & Beauty SE (the “Company”) initiated a written procedure (the “Written Procedure”) among the holders of the Company’s 2024/2028 bonds (ISIN: NO0013149658) (the “Bondholders” and the “Bonds”) in accordance with the terms and conditions of the Bonds for the purpose of carrying out a comprehensive restructuring of the Bonds and the Company’s capital structure.
The deadline for voting in the Written Procedure was 15:00 hrs CEST today. Votes representing a sufficient part of the adjusted nominal amount of the Bonds were obtained in order to form a quorum and a requisite majority of the adjusted nominal amount voted in favour of the amendments and the waivers in the Written Procedure.
Jörg Körfer, CEO of LR Health & Beauty SE, states: “The successful completion of the Written Procedure, the full subscription of the new bond tranche, and the full subscription of the new equity shares represent significant milestones on our path to successfully strengthen the Company’s capital structure. In this regard, the strong confidence from our stakeholders lays the foundation for us to now consistently drive forward the strategic and operational initiatives aimed at restoring and securing sustainable growth for the LR Group.”
Effectiveness of the Written Procedure
The amendments and waivers approved in the Written Procedure are conditional upon satisfaction of the following conditions, which are expected to be satisfied on or prior to 11 June 2026:
- completion of the EUR 11,764,705.88 (cash proceeds of EUR 10,000,000) share issue in Abydos S.à r.l. (the “Share Issue” and the “Parent”) and entry into the investment and shareholders' agreement by all investors in the Share Issue;
- transfer of all shares in the Company and the receivable under an existing EUR 4,000,000 shareholder loan from the Company’s existing shareholder to the Parent;
- entry into the amended and restated terms and conditions for the Bonds; and
- entry into the terms and conditions for the EUR 27,500,000 junior bonds to be issued by the Parent (the “Junior Bonds”).
Full Subscription of the Share Issue and the New Bond Issue
The Share Issue has been fully subscribed and is expected to be executed on 10 June 2026. The new bond issue of EUR 30,000,000 (total subscription price of EUR 10,000,000) under the amended and restated terms and conditions for the Bonds (the “New Bonds” and the “New Bond Issue”) has been fully subscribed and the New Bonds are expected to be issued on 17 June 2026.
Admission to Trading
The New Bonds are intended to be admitted to trading on the corporate bond list of Nasdaq Stockholm and listed on the Open Market of the Frankfurt Stock Exchange as soon as practically possible after the issue date of the New Bonds which is expected to be 17 June 2026.
The Junior Bonds are expected to be issued on 15 June 2026. The Junior Bonds shall be admitted to trading on the Open Market of the Frankfurt Stock Exchange within sixty (60) calendar days (with an intention of thirty (30) calendar days) of the issue date of the Junior Bonds, and on the Regulated Market of Nasdaq Stockholm (or another Regulated Market) within twelve (12) months of the issue date of the Junior Bonds.
Redemption of the Super Senior Bridge Bonds
The Company hereby gives notice to the holders of the Company’s super senior bridge bonds (ISIN: NO0013739029) issued by the Company on 26 March 2026 (the "Super Senior Bridge Bonds") of the redemption in full of the Super Senior Bridge Bonds on 22 June 2026. The redemption of the Super Senior Bridge Bonds is conditional upon the completion of the Share Issue and the New Bond Issue.
For further information regarding the Written Procedure and the restructuring measures set out therein, please refer to the notice of the Written Procedure which is accessible on the Company's website at https://ir.lrworld.com/en/bond/.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
Contact:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
IR Contact:
cometis AG
Thorben Burbach
Friedrichstrasse 22
65185 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
LR HEALTH & BEAUTY SE INITIATES A WRITTEN PROCEDURE UNDER ITS OUTSTANDING BOND LOAN IN RESPECT OF A COMPREHENSIVE RESTRUCTURING, PUBLISHES A PROSPECTUS FOR SUBSCRIPTION OF BONDS AND INVITES BONDHOLDERS TO SUBSCRIBE FOR SHARES IN ITS NEW PARENT COMPANY
Ahlen, 19 May 2026 – LR Health & Beauty SE (the “Company”) has today decided to initiate a written procedure (the “Written Procedure”) among the holders of the Company’s 2024/2028 bonds (ISIN: NO0013149658) (the “Bondholders” and the “Bonds”) in accordance with the terms and conditions of the Bonds (the “Terms and Conditions”) in order to implement the reorganization of the Company’s capital structure that has been agreed with Bondholders representing more than two thirds (2/3) of the nominal amount of the Bonds as well as the Company’s shareholder, as communicated by the Company on 11 February 2026 (the “Restructuring”). Bondholders representing more than two thirds (2/3) of the nominal amount of the Bonds have undertaken to vote in favour of the proposals in the Written Procedure.
Jörg Körfer, CEO of LR Health & Beauty SE, states: “The written procedure initiated today is part of the implementation of the agreed reorganization process to reorganize the Company’s capital structure. We very much welcome the continued commitment and support of all stakeholders to strengthen the capital basis of the Company. This commitment of all parties forms the basis of our strategic initiatives to restore and ensure the Company’s sustainable growth.”
In connection with the Written Procedure, and as a part of the Restructuring, holders of existing Bonds are offered (i) to subscribe for new Bonds pro rata in relation to their holdings of existing Bonds (the “New Bonds” and the “Bond Offering”) (see further under “The Bond Offering” below) and (ii) to subscribe for new shares in a newly incorporated holding company which shall be the sole shareholder of the Company following the Restructuring (the “Parent” and the “Share Issue”) (see further under “The Share Issue” below).
The Written Procedure and the Restructuring
The Restructuring comprises, inter alia, the following principal steps (each of which is described further in the notice of the Written Procedure):
- the amendment of the Terms and Conditions to enable the Restructuring;
- the write-down of EUR 70,000,000 of the nominal amount of the Bonds, pro rata amongst the Bondholders, EUR 20,000,000 of which will be reinstated into reinstated elevated bonds to be issued to Bondholders who elect to subscribe for New Bonds (as further set out below);
- the write-down of EUR 27,500,000 of the nominal amount of the Bonds, pro rata amongst the Bondholders in order to enable the reinstatement of such written-down nominal amount into unsecured and limited-recourse junior bonds of EUR 27,500,000 to be issued by the Parent, pro rata amongst the Bondholders;
- a write-down of all accrued and unpaid interest (including default interest (including NO0013736744 and NO0013699330 and the default ISIN to be generated for the regular May 2026 interest payment)) under the Bonds;
- the issuance of additional EUR 10,000,000 New Bonds to Bondholders who elect to subscribe for such Bonds in the Bond Offering, to be paid for in cash (or payment-in-kind by delivering super senior bonds with ISIN NO0013739029 (the “Super Senior Bridge Bonds”), as applicable);
- the reinstatement and issuance of EUR 20,000,000 Bonds on a pro rata basis to Bondholders who participate in the issuance of the New Bonds;
- the transfer of (i) all outstanding shares of the Company and (ii) all shareholder loans extended to the Company by the Company’s current shareholders to the Parent and waivers in respect thereto from the Bondholders;
- the Share Issue (as further described below);
- the provision of new security over the shares in the Company and a call option in respect of the shares in LR Health & Beauty Systems GmbH;
- certain structural corporate reorganisation measures to simplify the Group structure; and
- waivers of change of control occurring due to the Share Issue and certain events of default under the Terms and Conditions.
In order to implement the Restructuring, including the steps set out above, the Company has today initiated the Written Procedure. The last day for voting in the Written Procedure is 5 June 2026 and the voting record date is 21 May 2026. The notice of the Written Procedure and further details are accessible on the Company’s website at https://ir.lrworld.com/en/bond/.
In order to ensure that the Restructuring can be implemented as contemplated by the Written Procedure and provided that the Written Procedure is approved by the Bondholders, trading of existing Bonds and default interest ISINs will be blocked in the CSD systems from the business day following the Bondholders’ approval of the Written Procedure.
The Bond Offering
- The New Bonds and the reinstated elevated bonds will form an integral part of the same bond issue and will be issued within the same framework and under the same Terms and Conditions as the existing Bonds (as amended pursuant to the Written Procedure) in an aggregate nominal amount of EUR 30,000,000.
- The subscription price for the New Bonds is EUR 10,000,000 to be paid in cash (or by delivering Super Senior Bridge Bonds as payment-in-kind for New Bonds).
- All holders of existing Bonds are offered to subscribe for New Bonds pro rata in relation to their respective holdings of existing Bonds as of 21 May 2026. New Bonds not subscribed for by Bondholders on a pro rata basis will be allotted to the Backstop Providers as further described below.
- Certain existing Bondholders (together, the “Backstop Providers”), have committed to backstop the Bond Offering in full. Each Backstop Provider will subscribe for the New Bonds that are not subscribed for by other Bondholders, in proportion to each Backstop Provider’s pro rata share of the total nominal amount of the existing Bonds held by all Backstop Providers as of 11 March 2026. The Bond Offering is thereby fully backstopped.
- The completion of the Bond Offering is conditional upon:
- a sufficient number of holders of existing Bonds approving the Written Procedure and the conditions therein being satisfied;
- the completion of the Share Issue; and
- the transfer of all shares in the Company to the Parent.
- The subscription period for the New Bonds commences on 21 May 2026 and expires at 15.00 (CEST) on 29 May 2026. The issue date for the New Bonds is expected to be 17 June 2026.
- The Company aims to have the New Bonds admitted to trading on Nasdaq Stockholm (the “Admission to Trading”) no later than 60 calendar days (with the intention of 30 calendar days) from the issue date of the New Bonds, which is expected to be 17 June 2026.
The Company has prepared a prospectus regarding the Bond Offering which today has been approved by the Swedish Financial Supervisory Authority (the “Prospectus”). Further information on the Bond Offering and how to participate can be found in the notice of the Written Procedure and the Prospectus, both of which are available on the Company’s website at https://ir.lrworld.com/en/bond/.
The Share Issue
- The Share Issue entails a contribution of (i) EUR 10,576,470.59 comprising (a) a contribution in kind and assignment of the EUR 1,764,705.88 mandatory issuance fee under the terms and conditions of the Super Senior Bridge Bonds and (b) a contribution in cash in an amount of EUR 8,811,764.71 by Bondholders participating in the Share Issue, and (ii) EUR 1,188,235.29 by Project Artemis SCSp (an entity controlled by the Company’s current shareholder).
- A minimum investment requirement of EUR 100,000 applies to all participants in the Share Issue who are not Share Issue Backstop Providers (as defined below).
- In connection with the completion of the Share Issue, the shareholders of the Parent, including any Bondholders subscribing for shares in the Share Issue, will be required to enter into an investment and shareholders’ agreement in the form appended to the notice of the Written Procedure (the “Investment and Shareholders’ Agreement“) governing the rights and obligations of all shareholders of the Parent.
- Certain existing Bondholders (together, the “Share Issue Backstop Providers”), have committed to backstop the Share Issue in full. Each Share Issue Backstop Provider will subscribe for shares not validly subscribed for by other Bondholders. Thereby, EUR 8,811,764.71 of the cash subscription price in the Share Issue is fully backstopped.
- The subscription period for the Share Issue commences on 21 May 2026 and expires at 15:00 (CEST) on 29 May 2026. The Share Issue is expected to be executed on 10 June 2026.
- Following the Share Issue and completion of the Restructuring, the providers of the Super Senior Bridge Bonds will hold 15% of the shares in the Parent, Bondholders participating in the Share Issue will hold 74.9% of the shares in the Parent, and Project Artemis SCSp will hold 10.1% of the shares in the Parent.
Further information on the Share Issue and how to participate can be found in the notice of the Written Procedure which is available on the Company’s website at https://ir.lrworld.com/en/bond/. Applications to subscribe for shares shall be submitted to the Company in accordance with the instructions included in the notice of the Written Procedure.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
IR contact:
cometis AG
Thorben Burbach
Friedrichstrasse 22
65185 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
LR Health & Beauty SE publishes results for first quarter of 2026
LR Health & Beauty SE publishes results for first quarter of 2026
- Q1 2026 sales reached EUR 60.8 million, with normalized EBITDA of EUR 5.2 million
- Focus in FY 2026 on consistent continuation of strategic initiatives aimed at achieving sustainably positive business development
- Successful LR Business Days in April, featuring an innovative product launch, deliver additional momentum
Ahlen, 11 May 2026 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today publishes its preliminary figures for the first quarter of 2026.
Given generally subdued consumer sentiment in many European markets, the LR Group generated sales (revenue from goods sold) of EUR 60.8 million in the first three months of the 2026 financial year (Q1 2025: EUR 74.0 million), representing a 17.8% decrease compared with the same period last year. Normalized EBITDA reached EUR 5.2 million in the first quarter of 2026 (Q1 2025: EUR 8.2 million), whilst reported EBITDA stood at EUR 3.3 million (Q1 2025: EUR 7.4 million). The decrease in EBITDA is primarily attributable to the lower sales level as well as one-off effects relating to the ongoing financial restructuring.
Jörg Körfer, CEO of LR Health & Beauty SE, comments: “During the first quarter of 2026, we reached important milestones in the realignment of our financing structure. Accordingly, throughout the current year we will continue to focus on advancing our strategic initiatives in order to create the conditions for sustainably positive business development and growth. The successful outcome of our Business Days in April, attended by thousands of our distributors and featuring a promising product launch, clearly demonstrated that we can look to the future with confidence and achieve great success together with a strong partner community.”
LR continues to focus on the consistent expansion of its product portfolio with in-house production of selected top-selling health and beauty products. As part of the LR Business Days in April 2026, the relaunch of the 5in1 Beauty Elixir and the 5in1 Men’s Shot was presented, both of which are also to be manufactured in-house in future. The new products have already been received very positively by distributors, as reflected in the successful product launch. At the same time, in order to strengthen the partner community, the LR Group has introduced targeted adjustments to its career plan to support the successful career development of its distributors.
2025 Sustainability Report
In addition, LR has published its 2025 Sustainability Report. The report documents the company’s progress in the area of sustainability and underscores the LR Group’s commitment to combining economic success with environmental responsibility and social engagement. The Sustainability Report 2025 is available on the company’s website at https://ir.lrworld.com.
Annual Report 2025
LR will publish the audited annual and consolidated financial statements for the 2025 financial year following the completion of the financial restructuring process. As part of this, guidance for the current 2026 financial year will also be announced, as usual.
The preliminary report for the first quarter of 2026 is available online from today on the company’s website at https://ir.lrworld.com/.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
Contact:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
IR Contact:
cometis AG
Thorben Burbach
Friedrichstraße 22
65185 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
LR Health & Beauty SE announces successful conclusion of the Written Procedure initiated on 6 March 2026 under the 2024/2028 Bonds and issuance of Super Senior Bonds
LR Health & Beauty SE announces successful conclusion of the Written Procedure initiated on 6 March 2026 under the 2024/2028 Bonds and issuance of Super Senior Bonds
Ahlen, 24 March 2026 – On 6 March 2026, LR Health & Beauty SE (the “Company”) initiated a written procedure (the “Written Procedure”) under the terms and conditions for the Company’s 2024/2028 bonds (ISIN: NO0013149658) (the “Bonds”) to implement certain amendments to, and request certain temporary waivers under, the terms and conditions for the Bonds in order to inter alia enable the incurrence of a super senior bridge financing in the form of a new bond in the amount of EUR 10,000,000 which will rank super senior in relation to the Bonds (the “Super Senior Bond”).
Deadline for voting in the Written Procedure was 15:00 hrs CET today. Votes representing a sufficient part of the adjusted nominal amount of the Bonds were obtained in order to form a quorum and a requisite majority of the adjusted nominal amount voted in favour of the amendments and the temporary waivers in the Written Procedure. Consequently, the amendments and the temporary waivers are effective immediately and the Company will issue the Super Senior Bond on or about 26 March 2026.
For further information regarding the Written Procedure, please refer to the notice of the Written Procedure which is accessible on the Company’s website at https://ir.lrworld.com/en/bond/.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
Contact:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
IR Contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Building D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
LR Health & Beauty SE advances strategic realignment
LR Health & Beauty SE advances strategic realignment
- Strategic initiatives over the course of 2026 to provide tangible impetus for partners’ business activities
- Initiatives supported by financially strong investors
Ahlen, 6 March 2026 – LR Health & Beauty SE, Europe’s leading social commerce company in the area of high-quality health and beauty products, is taking the next step in its financial realignment. To this end, the Company today entered into further agreements that enable the company to implement targeted strategic initiatives for a sustainable positive business development.
Jörg Körfer, Chief Executive Officer (CEO) of LR Health & Beauty SE, explains: “The injection of fresh capital will advance our strategic realignment. In this respect, we are pleased to have financially strong partners at our side which secure and strengthen LR’s long-term financial stability and investment capacity. This will create the conditions for launching further targeted strategic initiatives in 2026. In April, our Business Days will be held with several thousand distribution partners. We will take this opportunity to present a promising product launch in the health and beauty area and further advance business with our partners. We will also inform our partner community about exciting news regarding our sales competitions and the LR car concept with the latter receiving its own showroom where partners will be able to celebrate the car handover in the future.”
In order to align business processes with future growth, LR is focusing, among other things, on inhouse production of selected products and efficiency enhancements through greater vertical integration. Accordingly, preparations are under way for the in-house production of an attractive top-selling product from the portfolio in order to benefit from improved scalability and flexibility. The project launched for this purpose is supported by the German Federal Ministry of Research, Technology and Space (BSFZ). The BSFZ supports projects that demonstrate a high level of entrepreneurial innovation capability.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
Contact:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
IR Contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Building D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de
LR Health & Beauty SE publishes Q4 2025 report and advances financial and strategic initiatives
LR Health & Beauty SE publishes Q4 2025 report and advances financial and strategic initiatives
- FY 2025 sales reached EUR 277.1 million on a preliminary basis, with EBITDA reported of EUR 16.5 million
- Focus on implementing a new financing structure and initiating targeted strategic measures for long-term business development and growth
- Planned launch of new generation of products combining health and beauty expertise demonstrates innovative strength and sets important impulses for 2026
Ahlen, 24 February 2026 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today publishes its results for the fourth quarter of 2025 as well as preliminary sales and earnings results for the 2025 financial year.
The LR Group continued to face generally subdued consumer sentiment in Western European markets in the fourth quarter of 2025. LR Health & Beauty SE achieved sales (revenue from goods sold) of EUR 68.2 million in the fourth quarter 2025 (Q4 2024: EUR 76.5 million), representing a decrease of 10.9%. Accordingly, over the course of the full 2025 year, LR Health & Beauty SE posted a 4.6% year-on-year lower level of sales of EUR 277.1 million on a preliminary basis (2024: EUR 289.2 million).
Furthermore, LR Health & Beauty SE achieved EBITDA reported of EUR 0.3 million in the fourth quarter of 2025 (Q4 2024: EUR 8.3 million). The results in the final quarter were particularly affected by the lower sales level and exceptional items as part of the realignment of the financing structure. For the full 2025 year, reported EBITDA on a preliminary basis amounted to EUR 16.5 million compared with EUR 27.3 million in 2024. Normalized EBITDA in the fourth quarter of 2025 decreased to EUR 3.4 million, compared with EUR 9.5 million in the fourth quarter of the previous year. Accordingly, over the full course of 2025, normalized EBITDA amounted to EUR 22.5 million on the basis of preliminary figures (2024: EUR 32.6 million).
Jörg Körfer, CEO of LR Health & Beauty SE, comments: “In both financial and strategic terms, we are focusing consistently on creating the preconditions for sustainably positive business growth. We have recently reached an important milestone with the agreement concerning a realignment of the financing structure. At the same time, it is important in 2026 to advance the LR Group’s business with suitable strategic initiatives. One focus in this context is the further development of our product portfolio. In the spring, we are planning the promising launch of a new generation of products that combines expertise from the health and beauty areas and will provide our distribution partners with fresh impetus for their business activities.”
In developing high-quality dietary supplements and cosmetic products, LR regularly draws on the latest findings from science and research. Sustainability aspects are also given special consideration when optimising the product portfolio – including in the upcoming product launch.
The report for the fourth quarter of 2025 is available online from today on the company’s website at https://ir.lrworld.com/. The final, audited results for the 2025 financial year will be published at the end of April 2026 with the Annual Report on the company’s website.
LR Group
Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.
Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.
The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.
In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.
Contact:
PR Contact:
LR Health & Beauty SE
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/
IR Contact:
cometis AG
Thorben Burbach
Unter den Eichen 7 | Building D
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de